2024 ICD-10-CM Diagnosis Code C63.02

by

Malignant neoplasm of left epididymis

  • C63.02 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
  • The 2024 edition of ICD-10-CM C63.02 became effective on October 1, 2023.
  • This is the American ICD-10-CM version of C63.02 – other international versions of ICD-10 C63.02 may differ.

ICD-10-CM Coding Rules

  • C63.02 is applicable to male patients.

The following code(s) above C63.02 contain annotation back-references

 that may be applicable to C63.02:

  • C00-D49  Neoplasms
  • C60-C63  Malignant neoplasms of male genital organs

Approximate Synonyms

  • Cancer, left epididymis
  • Epididymal cancer, bilateral epididymis
  • Primary malignant neoplasm of bilateral epididymes
  • Primary malignant neoplasm of left epididymis

ICD-10-CM C63.02 is grouped within Diagnostic Related Group(s) (MS-DRG v41.0):

  • 715 Other male reproductive system o.r. Procedures for malignancy with cc/mcc
  • 716 Other male reproductive system o.r. Procedures for malignancy without cc/mcc
  • 722 Malignancy, male reproductive system with mcc
  • 723 Malignancy, male reproductive system with cc
  • 724 Malignancy, male reproductive system without cc/mcc

Convert C63.02 to ICD-9-CMCode History

  • 2016 (effective 10/1/2015): New code (first year of non-draft ICD-10-CM)
  • 2017 (effective 10/1/2016): No change
  • 2018 (effective 10/1/2017): No change
  • 2019 (effective 10/1/2018): No change
  • 2020 (effective 10/1/2019): No change
  • 2021 (effective 10/1/2020): No change
  • 2022 (effective 10/1/2021): No change
  • 2023 (effective 10/1/2022): No change
  • 2024 (effective 10/1/2023): No change